Aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder in a patient with Charcot-Marie-Tooth disease type 1A

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy, and its involvement in the central nervous system (CNS) is very rare. We herein report a 51-year-old woman with CMT1A who suffered from recurrent optic neuritis and myelopathy. Under the diagnosis of anti-aquaporin-4 (anti-AQP4) antibody positive neuromyelitis optica spectrum disorder (NMOSD), we treated her successfully with corticosteroids. This is the first report of CMT1A complicated with anti-AQP4-positive NMOSD. Although the coexistence of the two disorders may simply be a coincidence, we speculated that immune cross-reaction between overexpressed peripheral myelin protein 22 and CNS myelin may have caused concomitant CMT1A and NMOSD.

Cite

CITATION STYLE

APA

Hamada, Y., Takahashi, K., Kanbayashi, T., Hatanaka, Y., Kobayashi, S., & Sonoo, M. (2021). Aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder in a patient with Charcot-Marie-Tooth disease type 1A. Internal Medicine, 60(10), 1611–1614. https://doi.org/10.2169/INTERNALMEDICINE.6153-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free